Tackling the Next Generation of Resistance in EGFR-Mutant Lung Cancer

J Thorac Oncol. 2017 Mar;12(3):419-421. doi: 10.1016/j.jtho.2017.01.018.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • Drug Resistance, Neoplasm / drug effects
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms*
  • Mutation / drug effects
  • Protein Kinase Inhibitors

Substances

  • Protein Kinase Inhibitors
  • ErbB Receptors